Natixis Advisors, L.P. Dexcom Inc Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Dexcom Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 227,091 shares of DXCM stock, worth $15 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
227,091
Previous 150,944
50.45%
Holding current value
$15 Million
Previous $10.3 Million
92.31%
% of portfolio
0.03%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding DXCM
# of Institutions
1,110Shares Held
370MCall Options Held
5.32MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$3.19 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.28 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.11 Billion0.06% of portfolio
-
Baillie Gifford & CO16.7MShares$1.1 Billion1.14% of portfolio
-
Jennison Associates LLC11.5MShares$761 Million0.6% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...